Indication
Erythroplakia
3 clinical trials
2 products
1 drug
Clinical trial
M4OC-Prevent: Metformin for Oral Cancer PreventionStatus: Active (not recruiting), Estimated PCD: 2017-10-12
Drug
MetforminClinical trial
M4OC-Prevent 2.0: Phase IIb Trial of Metformin for Oral Cancer PreventionStatus: Recruiting, Estimated PCD: 2026-08-31
Product
Extended Release MetforminProduct
PlaceboClinical trial
Metformin Chemoprevention of Oral Premalignant LesionsStatus: Terminated, Estimated PCD: 2024-03-16